# Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

> **NCT00212628** · PHASE3 · COMPLETED · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 444 (actual)

## Conditions studied

- Involutional Osteoporosis

## Interventions

- **DRUG:** Minodronic acid hydrate

## Key facts

- **NCT ID:** NCT00212628
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 444 (ACTUAL)
- **Last updated:** 2012-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00212628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00212628, "Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00212628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*